SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 336 filers reported holding SHOCKWAVE MED INC in Q2 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,497,507 | -39.2% | 62,770 | -12.9% | 0.02% | -43.2% |
| Q2 2023 | $20,563,791 | +16.7% | 72,050 | -11.4% | 0.04% | +19.4% |
| Q1 2023 | $17,623,942 | +27.3% | 81,280 | +20.7% | 0.03% | +14.8% |
| Q4 2022 | $13,840,432 | +255.0% | 67,314 | +380.0% | 0.03% | +237.5% |
| Q3 2022 | $3,899,000 | +26.4% | 14,023 | -13.1% | 0.01% | +166.7% |
| Q2 2022 | $3,084,000 | +112.5% | 16,132 | +98.2% | 0.00% | +200.0% |
| Q4 2021 | $1,451,000 | -13.1% | 8,138 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $1,669,000 | +11.5% | 8,105 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $1,497,000 | -81.9% | 7,891 | -90.1% | 0.00% | -87.5% |
| Q4 2020 | $8,268,000 | -8.6% | 79,708 | -33.2% | 0.01% | -27.3% |
| Q3 2020 | $9,047,000 | +2.0% | 119,353 | -36.2% | 0.01% | +10.0% |
| Q2 2020 | $8,867,000 | +4005.1% | 187,175 | +2781.4% | 0.01% | – |
| Q1 2020 | $216,000 | -86.3% | 6,496 | -81.9% | 0.00% | -100.0% |
| Q4 2019 | $1,575,000 | – | 35,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |